Your browser doesn't support javascript.
loading
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2.
Galipeau, Yannick; Siragam, Vinayakumar; Laroche, Geneviève; Marion, Erika; Greig, Matthew; McGuinty, Michaeline; Booth, Ronald A; Durocher, Yves; Cuperlovic-Culf, Miroslava; Bennett, Steffany A L; Crawley, Angela M; Giguère, Patrick M; Cooper, Curtis; Langlois, Marc-André.
Afiliación
  • Galipeau Y; Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada.
  • Siragam V; Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada.
  • Laroche G; Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada.
  • Marion E; Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada.
  • Greig M; Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada.
  • McGuinty M; The Ottawa Hospital Research Institute.
  • Booth RA; University of Ottawa & The Ottawa Hospital Department of Pathology and Laboratory Medicine and The Eastern Ontario Regional Laboratory Association (EORLA).
  • Durocher Y; Human Health Therapeutics Research Center, National Research Council Canada.
  • Cuperlovic-Culf M; Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada; Digital Technologies Research Center, National Research Council Canada; Ottawa Institute of Systems Biology.
  • Bennett SAL; Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada; Ottawa Institute of Systems Biology; University of Ottawa Centre for Infection, Immunity and Inflammation (CI3).
  • Crawley AM; Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada; The Ottawa Hospital Research Institute; University of Ottawa Centre for Infection, Immunity and Inflammation (CI3); Department of Biology, Carleton University, Canada.
  • Giguère PM; Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada.
  • Cooper C; The Ottawa Hospital Research Institute.
  • Langlois MA; Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada; University of Ottawa Centre for Infection, Immunity and Inflammation (CI3). Electronic address: langlois@uottawa.ca.
EBioMedicine ; 74: 103700, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34861490
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Coronavirus Humano 229E / Coronavirus Humano OC43 / Coronavirus Humano NL63 / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / Anticuerpos Antivirales Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: EBioMedicine Año: 2021 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Coronavirus Humano 229E / Coronavirus Humano OC43 / Coronavirus Humano NL63 / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / Anticuerpos Antivirales Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: EBioMedicine Año: 2021 Tipo del documento: Article País de afiliación: Canadá